Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00799357 · ClinicalTrials.gov registry record
Utility of Bedside Ultrasound in the Prediction of Difficult Airway
A clinical trial of Laryngoscopy, sponsored by University of Nebraska.
- Completed
- Registry status
- 162
- Enrollment target
- 1
- Study location
NCT00799357: Completed study of Laryngoscopy, sponsored by University of Nebraska.
NCT00799357 is a study of Laryngoscopy that has completed, run by University of Nebraska. The registered enrollment target is 162 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00799357, a study of Laryngoscopy, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the utility of bedside ultrasound to predict difficult airway in patients requiring emergency intubation.
Conditions Studied
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2008-12-09 |
| Est. Completion | 2009-06-01 |
What the finished NCT00799357 record still lists
NCT00799357 is an observational study that tracks outcomes without assigning an intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Laryngoscopy appearing as the primary indexed condition, and to 0 interventions.
NCT00799357 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT00799357 about?
NCT00799357 is a clinical study titled "Utility of Bedside Ultrasound in the Prediction of Difficult Airway". The purpose of this study is to assess the utility of bedside ultrasound to predict difficult airway in patients requiring emergency intubation.
What is the current status of trial NCT00799357?
This trial is currently completed. The enrollment target is 162 participants. The study started on 2008-12-09. Estimated completion is 2009-06-01.
What conditions does trial NCT00799357 study?
This clinical trial studies the following conditions: Laryngoscopy.
Who is sponsoring clinical trial NCT00799357?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00799357 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Laryngoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI